Condition
Central Line Infection
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Unknown1
Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06085690Not ApplicableRecruiting
Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science
NCT04541446Not ApplicableCompleted
Study Dynamic Haptic Robotic Trainer (DHRT) and DHRT+ for CVC Insertion Training for Surgical Residents
NCT04522778Not ApplicableTerminated
Innovative Central Line Securement Device in the Pediatric Population
NCT01960556CompletedPrimary
Simulation-Based Central Venous Line Maintenance Bundle Education
NCT01082770Phase 4Unknown
Randomised Controlled Trial of Needle Free Access Devices in Preventing Hemodialysis Blood Stream Infection
Showing all 5 trials